• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在Ts65Dn小鼠中模拟阿尔茨海默病相关表型:年龄对Aβ、Tau、pTau、NfL及行为的影响

Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behavior.

作者信息

Overk Cassia, Fiorini Emma, Babolin Chiara, Vukicevic Marija, Morici Catherine, Madani Rime, Eligert Valerie, Kosco-Vilbois Marie, Roberts Amanda, Becker Ann, Pfeifer Andrea, Mobley William C

机构信息

Department of Neurosciences, University of California, San Diego, La Jolla, CA, United States.

AC Immune SA, Lausanne, Switzerland.

出版信息

Front Neurosci. 2023 Jun 28;17:1202208. doi: 10.3389/fnins.2023.1202208. eCollection 2023.

DOI:10.3389/fnins.2023.1202208
PMID:37449271
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10336548/
Abstract

INTRODUCTION

People with DS are highly predisposed to Alzheimer's disease (AD) and demonstrate very similar clinical and pathological features. Ts65Dn mice are widely used and serve as the best-characterized animal model of DS.

METHODS

We undertook studies to characterize age-related changes for AD-relevant markers linked to Aβ, Tau, and phospho-Tau, axonal structure, inflammation, and behavior.

RESULTS

We found age related changes in both Ts65Dn and 2N mice. Relative to 2N mice, Ts65Dn mice showed consistent increases in Aβ40, insoluble phospho-Tau, and neurofilament light protein. These changes were correlated with deficits in learning and memory.

DISCUSSION

These data have implications for planning future experiments aimed at preventing disease-related phenotypes and biomarkers. Interventions should be planned to address specific manifestations using treatments and treatment durations adequate to engage targets to prevent the emergence of phenotypes.

摘要

引言

唐氏综合征患者极易患阿尔茨海默病(AD),并表现出非常相似的临床和病理特征。Ts65Dn小鼠被广泛使用,是唐氏综合征特征最明确的动物模型。

方法

我们开展了研究,以表征与Aβ、Tau和磷酸化Tau、轴突结构、炎症及行为相关的AD相关标志物的年龄相关变化。

结果

我们在Ts65Dn小鼠和2N小鼠中均发现了年龄相关变化。相对于2N小鼠,Ts65Dn小鼠的Aβ40、不溶性磷酸化Tau和神经丝轻链蛋白持续增加。这些变化与学习和记忆缺陷相关。

讨论

这些数据对于规划未来旨在预防疾病相关表型和生物标志物的实验具有启示意义。应规划干预措施,使用足以作用于靶点的治疗方法和治疗持续时间来应对特定表现,以预防表型的出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/eda85ebafe5d/fnins-17-1202208-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/68e799bf4238/fnins-17-1202208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/7043331b4c4a/fnins-17-1202208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/9e6f1e23cd89/fnins-17-1202208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/7ea43a67b8fe/fnins-17-1202208-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/eda85ebafe5d/fnins-17-1202208-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/68e799bf4238/fnins-17-1202208-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/7043331b4c4a/fnins-17-1202208-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/9e6f1e23cd89/fnins-17-1202208-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/7ea43a67b8fe/fnins-17-1202208-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e975/10336548/eda85ebafe5d/fnins-17-1202208-g005.jpg

相似文献

1
Modeling Alzheimer's disease related phenotypes in the Ts65Dn mouse: impact of age on Aβ, Tau, pTau, NfL, and behavior.在Ts65Dn小鼠中模拟阿尔茨海默病相关表型:年龄对Aβ、Tau、pTau、NfL及行为的影响
Front Neurosci. 2023 Jun 28;17:1202208. doi: 10.3389/fnins.2023.1202208. eCollection 2023.
2
Temporal and brain region-specific elevations of soluble Amyloid-β in the Ts65Dn mouse model of Down syndrome and Alzheimer's disease.唐氏综合征和阿尔茨海默病 Ts65Dn 小鼠模型中可溶性淀粉样蛋白-β的时间和脑区特异性升高。
Aging Cell. 2022 Apr;21(4):e13590. doi: 10.1111/acel.13590. Epub 2022 Mar 15.
3
Dynamics of plasma biomarkers in Down syndrome: the relative levels of Aβ42 decrease with age, whereas NT1 tau and NfL increase.唐氏综合征患者血浆生物标志物的动态变化:Aβ42 相对水平随年龄下降,而 NT1 tau 和 NfL 则增加。
Alzheimers Res Ther. 2020 Mar 19;12(1):27. doi: 10.1186/s13195-020-00593-7.
4
Behavioral and neurobiological markers of Alzheimer's disease in Ts65Dn mice: effects of estrogen.Ts65Dn小鼠中阿尔茨海默病的行为和神经生物学标志物:雌激素的作用。
Neurobiol Aging. 2004 Aug;25(7):873-84. doi: 10.1016/j.neurobiolaging.2003.10.010.
5
Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals.中国个体中可能患有阿尔茨海默病痴呆症的血浆β-淀粉样蛋白、tau蛋白、神经退行性变生物标志物及炎症因子
Front Aging Neurosci. 2022 Aug 18;14:963845. doi: 10.3389/fnagi.2022.963845. eCollection 2022.
6
Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease.非β-淀粉样蛋白/tau 脑脊液标志物可提示阿尔茨海默病的分期和进展。
Alzheimers Res Ther. 2018 Sep 25;10(1):98. doi: 10.1186/s13195-018-0426-3.
7
Normalizing the gene dosage of Dyrk1A in a mouse model of Down syndrome rescues several Alzheimer's disease phenotypes.唐氏综合征小鼠模型中 Dyrk1A 基因剂量的正常化可挽救几种阿尔茨海默病表型。
Neurobiol Dis. 2017 Oct;106:76-88. doi: 10.1016/j.nbd.2017.06.010. Epub 2017 Jun 21.
8
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease.阿尔茨海默病中的脑脊液tau蛋白、神经颗粒素和神经丝轻链蛋白
EMBO Mol Med. 2016 Oct 4;8(10):1184-1196. doi: 10.15252/emmm.201606540. Print 2016 Oct.
9
Effects of Maternal Choline Supplementation on the Septohippocampal Cholinergic System in the Ts65Dn Mouse Model of Down Syndrome.孕期补充胆碱对唐氏综合征 Ts65Dn 小鼠模型中隔海马胆碱能系统的影响。
Curr Alzheimer Res. 2016;13(1):84-96. doi: 10.2174/1567205012666150921100515.
10
Profiling Basal Forebrain Cholinergic Neurons Reveals a Molecular Basis for Vulnerability Within the Ts65Dn Model of Down Syndrome and Alzheimer's Disease.基底前脑胆碱能神经元分析揭示唐氏综合征和阿尔茨海默病 Ts65Dn 模型中易损性的分子基础。
Mol Neurobiol. 2021 Oct;58(10):5141-5162. doi: 10.1007/s12035-021-02453-3. Epub 2021 Jul 14.

引用本文的文献

1
Charting the future: current and future directions in translational research for individuals with Down syndrome.规划未来:唐氏综合征患者转化研究的现状与未来方向
J Neurodev Disord. 2025 Jul 8;17(1):38. doi: 10.1186/s11689-025-09630-8.
2
Altered Brain Cholesterol Machinery in a Down Syndrome Mouse Model: A Possible Common Feature with Alzheimer's Disease.唐氏综合征小鼠模型中大脑胆固醇机制的改变:与阿尔茨海默病的一个可能共同特征。
Antioxidants (Basel). 2024 Apr 3;13(4):435. doi: 10.3390/antiox13040435.

本文引用的文献

1
The Importance of CXCL1 in the Physiological State and in Noncancer Diseases of the Oral Cavity and Abdominal Organs.CXCL1 在口腔和腹部器官的生理状态及非癌症疾病中的重要性。
Int J Mol Sci. 2022 Jun 28;23(13):7151. doi: 10.3390/ijms23137151.
2
Association of Alzheimer Disease With Life Expectancy in People With Down Syndrome.阿尔茨海默病与唐氏综合征患者预期寿命的关联。
JAMA Netw Open. 2022 May 2;5(5):e2212910. doi: 10.1001/jamanetworkopen.2022.12910.
3
Impact of increased APP gene dose in Down syndrome and the Dp16 mouse model.
唐氏综合征中 APP 基因剂量增加的影响及 Dp16 小鼠模型。
Alzheimers Dement. 2022 Jun;18(6):1203-1234. doi: 10.1002/alz.12463. Epub 2021 Nov 10.
4
Integrating Biomarker Outcomes into Clinical Trials for Alzheimer's Disease in Down Syndrome.将生物标志物结果纳入唐氏综合征阿尔茨海默病临床试验中。
J Prev Alzheimers Dis. 2021;8(1):48-51. doi: 10.14283/jpad.2020.35.
5
Evolution of neuroinflammation across the lifespan of individuals with Down syndrome.唐氏综合征个体生命历程中的神经炎症演变。
Brain. 2020 Dec 1;143(12):3653-3671. doi: 10.1093/brain/awaa326.
6
Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.靶向唐氏综合征中 APP 水平升高:Posiphen 介导的 APP 及其产物减少可逆转 Ts65Dn 小鼠模型中的内体表型。
Alzheimers Dement. 2021 Feb;17(2):271-292. doi: 10.1002/alz.12185. Epub 2020 Sep 25.
7
Neurofilament light as a blood biomarker for neurodegeneration in Down syndrome.神经丝轻链作为唐氏综合征神经退行性变的血液生物标志物。
Alzheimers Res Ther. 2018 Apr 10;10(1):39. doi: 10.1186/s13195-018-0367-x.
8
Aberrations in circulating inflammatory cytokine levels in patients with Down syndrome: a meta-analysis.唐氏综合征患者循环炎症细胞因子水平的异常:一项荟萃分析。
Oncotarget. 2017 Sep 19;8(48):84489-84496. doi: 10.18632/oncotarget.21060. eCollection 2017 Oct 13.
9
Serum neurofilament light in familial Alzheimer disease: A marker of early neurodegeneration.家族性阿尔茨海默病中的血清神经丝轻链:早期神经退行性变的标志物。
Neurology. 2017 Nov 21;89(21):2167-2175. doi: 10.1212/WNL.0000000000004667. Epub 2017 Oct 25.
10
A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome.唐氏综合征患者痴呆的前瞻性 20 年纵向随访。
J Intellect Disabil Res. 2017 Sep;61(9):843-852. doi: 10.1111/jir.12390. Epub 2017 Jun 29.